Novo Nordisk Foundation establishes Danish Diabetes and Endocrine Academy

A new grant from the Novo Nordisk Foundation has been used to establish a new educational facility which will aim to improve the quality of Danish research and teaching within diabetes and endocrinology.

Photo: Novo Nordisk Fonden / PR

The Novo Nordisk Foundation has granted DKK 195m (USD 27m) to establish the Danish Diabetes and Endocrine Academy (DDEA).

In a press release, the foundation writes that the aim of the academy will be to develop and improve the quality of Danish research and education within diabetes and endocrinology. The academy will provide support to PhD and postdoc funds, arrange and facilitate education and networking events and create national and international partnerships with universities, hospitals, the life science industry and NGOs across several research disciplines.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs